drugset / Trial / NCT00122733

Loxapine and Weaning From Ventilator

NCT00122733

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Patients may be very agitated during the weaning period from mechanical ventilation. Administration of loxapine, a neuroleptic that does not notably affect ventilatory drive, may help in obtaining an adequate level of cooperation and, therefore, in reducing the duration of mechanical ventilation.

Timeline

Start
2005-12
Primary completion
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject loxapine Small molecule 150 mg Other

Indications